Clinical Trial Update: Effect of Probiotic Lactobacillus Reuteri in the Treatment of Mucositis and Periimplantitis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of probiotic Lactobacillus reuteri in treating mucositis and peri-implantitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucositis
• Peri-implantitis

Drugs mentioned

• Lactobacillus reuteri (Lactobacillus reuteri)

Snippet

Sponsor: Universitat Internacional de Catalunya | Conditions: Mucositis, Peri-implantitis | Phase 4 | Status: COMPLETED